CPH 0.00% 0.9¢ creso pharma limited

Why wouldn't you buy?, page-48

  1. 1,612 Posts.
    lightbulb Created with Sketch. 245
    Yeah the attempted boardroom coup over at ESE must be such a distraction for the company. The terpenes market is tough enough without something like that happening. As FraserJC himself said on this forum: "there are already lots of companies selling terpenes B2B and B2C, so gaining market share will be expensive. Google “terpenes” and you’ll be amazed."
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.